Florence Joly-Lobbedez
Caen, 14000, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Maintenance olaparib after platinum-based chemotherapy for advanced/metastatic endometrial cancer: GINECO randomized phase IIb UTOLA trial.
Journal: Nature communications
Published: March 07, 2025
The PENDOR study: establishment of a panel of patient-derived tumor organoids from endometrial cancer to assess efficacy of PARP inhibitors.
Journal: BMC cancer
Published: December 20, 2024
Gene expression markers in peripheral blood and outcome in patients with platinum-resistant ovarian cancer: A study of the European GANNET53 consortium.
Journal: International journal of cancer
Published: September 25, 2023
Improve the management of cancer-related cognitive impairment in clinical settings: a European Delphi study.
Journal: Journal of cancer survivorship : research and practice
Published: June 09, 2023
Atezolizumab plus Magrolimab, Niraparib, or Tocilizumab versus Atezolizumab Monotherapy in Platinum-Refractory Metastatic Urothelial Carcinoma: A Phase Ib/II Open-Label, Multicenter, Randomized Umbrella Study (MORPHEUS Urothelial Carcinoma).
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 29, 2023
Efficacy and safety of nivolumab in bone metastases from renal cell carcinoma: Results of the GETUG-AFU26-NIVOREN multicentre phase II study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: December 01, 2022
Neoadjuvant chemotherapy with or without nintedanib for advanced epithelial ovarian cancer: Lessons from the GINECO double-blind randomized phase II CHIVA trial.
Journal: Gynecologic oncology
Published: November 21, 2022
Erratum to "GCIG-Consensus guideline for long-term survivorship in gynecologic cancer: A position paper from the Gynecologic Cancer InterGroup (GCIG) symptom benefit committee" [Cancer Treatm. Rev. 107 (2022) 102396].
Journal: Cancer treatment reviews
Published: July 08, 2022
Paclitaxel with or without pazopanib for ovarian cancer relapsing during bevacizumab maintenance therapy: The GINECO randomized phase II TAPAZ study.
Journal: Gynecologic oncology
Published: April 14, 2022
GCIG-Consensus guideline for Long-term survivorship in gynecologic Cancer: A position paper from the gynecologic cancer Intergroup (GCIG) symptom benefit committee.
Journal: Cancer treatment reviews
Published: March 30, 2022
Metastatic renal cell carcinoma: Management of toxicities of combinations
Journal: Bulletin du cancer
Published: January 20, 2022
Last Updated: 09/26/2026